首页> 外文期刊>The journal of clinical endocrinology and metabolism >Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH

【24h】

Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH

机译：甲状腺癌患者有远处转移的甲状腺癌患者的五年生存率相似，这些患者已准备好通过甲状腺激素戒断或重组人TSH进行放射性碘治疗。

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Context:Elevated levels of TSH markedly enhance the effectiveness of radioiodine (RAI) therapy in metastatic thyroid cancer.

机译：背景：TSH水平升高可显着提高放射性碘（RAI）治疗转移性甲状腺癌的有效性。

著录项

来源
《The journal of clinical endocrinology and metabolism》 |2011年第7期|共7页
作者
H. Tala; R. Robbins; J. A. Fagin; S. M. Larson; R. M. Tuttle;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH [J] . H. Tala, R. Robbins, J. A. Fagin, The journal of clinical endocrinology and metabolism . 2011,第7期

机译：甲状腺癌患者有远处转移的甲状腺癌患者的五年生存率相似，这些患者已准备好通过甲状腺激素戒断或重组人TSH进行放射性碘治疗。
2. Recombinant human TSH versus thyroid hormone withdrawal in adjuvant therapy with radioactive iodine of patients with papillary thyroid carcinoma and clinically apparent lymph node metastases not limited to the central compartment (cN1b) [J] . Pedro Weslley Rosario, Maria Regina Calsolari, Gabriela Franco Mour?o Archives of Endocrinology and Metabolism . 2017,第2期

机译：甲状腺乳头状癌且临床上明显的淋巴结转移不限于中央区室（cN1b）的患者，在放射性碘辅助治疗中重组人TSH与甲状腺激素撤药
3. Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity 131I After Either Recombinant Human TSH or Thyroid Hormone Therapy Withdrawal Showed the Same Outcome After a 10-Year Follow-up [J] . Eleonora Molinaro, Carlotta Giani, Laura Agate, The journal of clinical endocrinology and metabolism . 2013,第7期

机译：重组人TSH或甲状腺激素治疗退出后接受低碘131I放射性碘甲状腺消融的分化型甲状腺癌患者在随访10年后仍显示相同的结果
4. Radioablative Therapy with Iodine-131 on a Patient with Thyroid Cancer and Chronic Renal Failure in Hemodialysis First Experience in Peru [C] . Apaza Veliz D.G, Herrera Vera R.D, Cardenas Abarca C.A, Latin American Symposium on Nuclear Physics and Applications . 2016

机译：用碘-131对血液透析血液透析患者碘-131对患者的可放射性疗法及血液透析的慢性肾功能衰竭
5. Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive Iodine Treatment of Differentiated Thyroid Cancer with Nodal Metastatic Disease [O] . Robert M. Wolfson, Irina Rachinsky, Deric Morrison, 2016

机译：重组人甲状腺刺激激素与甲状腺激素戒断在放射性碘治疗分化型淋巴结转移性甲状腺癌中的作用
6. Recombinant human TSH versus thyroid hormone withdrawal in adjuvant therapy with radioactive iodine of patients with papillary thyroid carcinoma and clinically apparent lymph node metastases not limited to the central compartment (cN1b) [O] . Pedro Weslley Rosario, Gabriela Franco Mourão, Maria Regina Calsolari 2017

机译：重组人TSH与甲状腺激素戒断在助剂治疗中，乳头状甲状腺癌患者的放射性碘和临床表观淋巴结转移不限于中央隔室（CN1B）
7. Effect of Iodine Refeeding on Thyroid Hormones Synthesis and Secretion after a Long Iodine Deficiency. Preferential T3 Secretion and TSH Regulation [R] . Rognoni, J. B., Berthier, C., Simon, C., 1978

机译：碘缺乏对长期碘缺乏后甲状腺激素合成和分泌的影响。优先T3分泌和TsH法规

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号